Pasithea Therapeutics logo

Pasithea Therapeutics share price today

(KTTA)

Pasithea Therapeutics share price is $3.09 & ₹265.15 as on 7 Jan 2025, 2.30 'hrs' IST

$3.09

-0.03

(-0.96%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Pasithea Therapeutics share price in Dollar and Rupees. Guide to invest in Pasithea Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pasithea Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Pasithea Therapeutics share price movements

  • Today's Low: $3.06
    Today's High: $3.17

    Day's Volatility :3.52%

  • 52 Weeks Low: $2.37
    52 Weeks High: $9.25

    52 Weeks Volatility :74.38%

Pasithea Therapeutics Returns

PeriodPasithea Therapeutics CorpIndex (Russel 2000)
3 Months
-33.76%
0.0%
6 Months
-43.98%
0.0%
1 Year
-57.56%
0.0%
3 Years
-89.46%
-19.8%

Pasithea Therapeutics Key Statistics

in dollars & INR

Previous Close
$3.12
Open
$3.17
Today's High
$3.1715
Today's Low
$3.06
Market Capitalization
$4.0M
Today's Volume
$62.5K
52 Week High
$9.25
52 Week Low
$2.37
Revenue TTM
$486.6K
EBITDA
$-16.3M
Earnings Per Share (EPS)
$-14.79
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.25%

How to invest in Pasithea Therapeutics from India?

It is very easy for Indian residents to invest directly in Pasithea Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pasithea Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pasithea Therapeutics or KTTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pasithea Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pasithea Therapeutics shares which would translate to 0.278 fractional shares of Pasithea Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pasithea Therapeutics, in just a few clicks!

Returns in Pasithea Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pasithea Therapeutics investment value today

Current value as on today

₹45,263

Returns

₹54,737

(-54.74%)

Returns from Pasithea Therapeutics Stock

₹57,959 (-57.96%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Pasithea Therapeutics

0%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Pasithea Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 0% more investors are searching Pasithea Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Pasithea Therapeutics

  • UBS Group AG

    0.52%

  • Morgan Stanley - Brokerage Accounts

    0.12%

  • Tower Research Capital LLC

    0.05%

  • Royal Bank of Canada

    0.02%

  • JPMorgan Chase & Co

    0.01%

Analyst Recommendation on Pasithea Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pasithea Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pasithea Therapeutics

What analysts predicted

Downside of 35.28%

Current:

$3.09

Target:

$2.00

Insights on Pasithea Therapeutics

  • Price Movement

    In the last 3 months, KTTA stock has moved down by -41.6%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 13.58K → 976.30K (in $), with an average increase of 59.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.86M → -2.99M (in $), with an average increase of 28.9% per quarter
  • KTTA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 79.1%
  • KTTA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 145.2%
  • Price to Sales

    ForKTTA every $1 of sales, investors are willing to pay $8.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Pasithea Therapeutics Technicals Summary

Sell

Neutral

Buy

Pasithea Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pasithea Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pasithea Therapeutics Corp
2.3%
-43.98%
-57.56%
-89.46%
-95.62%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pasithea Therapeutics Corp
NA
NA
NA
0.0
-0.63
-0.38
NA
22.46
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pasithea Therapeutics Corp
Buy
$4.0M
-95.62%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Pasithea Therapeutics

Organization
Pasithea Therapeutics
Employees
8
CEO
Dr. Lawrence Steinman BA, M.D., Ph.D.
Industry
Miscellaneous

Management People of Pasithea Therapeutics

NameTitle
Dr. Lawrence Steinman BA, M.D., Ph.D.
Co-Founder, MD & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.
CEO & Director
Mr. Daniel H. Schneiderman
Chief Financial Officer
Dr. Graeme Currie Ph.D.
Chief Development Officer
Dr. Yassine Bendiabdallah Ph.D.
COO & Head of UK Clinics

Important FAQs about investing in Pasithea Therapeutics from India :

What is Pasithea Therapeutics share price today?

Pasithea Therapeutics share price today stands at $3.09, Open: $3.17 ; Previous Close: $3.12 ; High: $3.17 ; Low: $3.06 ; 52 Week High: $9.25 ; 52 Week Low: $2.37. The stock opens at $3.17, after a previous close of $3.12. The stock reached a daily high of $3.17 and a low of $3.06, with a 52-week high of $9.25 and a 52-week low of $2.37.

Can Indians buy Pasithea Therapeutics shares?

Yes, Indians can invest in the Pasithea Therapeutics (KTTA) from India.

With INDmoney, you can buy Pasithea Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pasithea Therapeutics at zero transaction cost.

How can I buy Pasithea Therapeutics shares from India?

It is very easy to buy Pasithea Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pasithea Therapeutics be purchased?

Yes, you can buy fractional shares of Pasithea Therapeutics with INDmoney app.

What are the documents required to start investing in Pasithea Therapeutics stocks?

To start investing in Pasithea Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pasithea Therapeutics

Today’s highest price of Pasithea Therapeutics (KTTA) is $3.17.

Today’s lowest price of Pasithea Therapeutics (KTTA) is $3.06.

What is today's market capitalisation of Pasithea Therapeutics

Today's market capitalisation of Pasithea Therapeutics KTTA is 4.0M

What is the 52 Week High and Low Range of Pasithea Therapeutics

  • 52 Week High

    $9.25

  • 52 Week Low

    $2.37

What are the historical returns of Pasithea Therapeutics?

  • 1 Month Returns

    2.3%

  • 3 Months Returns

    -43.98%

  • 1 Year Returns

    -57.56%

  • 5 Years Returns

    -95.62%

Who is the Chief Executive Officer (CEO) of Pasithea Therapeutics

Dr. Lawrence Steinman BA, M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pasithea Therapeutics.